29 results
424B3
l466tnd1ml 8sxvzj
4 Apr 23
Prospectus supplement
4:57pm
POS AM
dv44o3wngx9q
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
PRE 14A
8nltre71puskvt332f
21 Apr 22
Preliminary proxy
4:33pm
424B4
20iagr
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
2614okwhra9vhv
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
DRS
EX-1.1
grbcsz
2 Jun 21
Draft registration statement
12:00am
DRS
o2oq62zhd1cly6l32
2 Jun 21
Draft registration statement
12:00am
DEFA14A
jud5sve c8trxc3j9k
30 Apr 21
Additional proxy soliciting materials
5:21pm
DEF 14A
l66o 5ohwc
30 Apr 21
Definitive proxy
5:20pm
10-K
bhji8
31 Mar 21
Annual report
2:14pm